SELLIZA HISTORY
Selliza has expanded from a tiny HRT research lab to a medium-sized pharmaceutical firm in the course of its 15-year existence. Our skilled lab technicians and pharmacists, together with the cutting-edge equipment we have on hand, allow us to confidently guarantee that our various medication options will take care of your hormone replacement treatment. Increasing the scope of our studies before the end of 2024 and in the years after we began producing selective androgen receptor modulators, or SARMs. We will be pleased to present our new peptide product range. Our firm is scheduled to begin producing growth hormone in 2025.
We are able to take on the most difficult problems in healthcare because of our strong R&D organization, love for what we do, and independence in problem-solving.